Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Royalty or License | $24,941 | 52 | 64.7% |
| Honoraria | $11,335 | 2 | 29.4% |
| Travel and Lodging | $2,040 | 1 | 5.3% |
| Food and Beverage | $217.37 | 4 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Becton, Dickinson and Company | $24,941 | 52 | $0 (2024) |
| CSL Behring | $13,592 | 7 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,170 | 8 | Becton, Dickinson and Company ($4,170) |
| 2023 | $3,733 | 9 | Becton, Dickinson and Company ($3,733) |
| 2022 | $3,723 | 8 | Becton, Dickinson and Company ($3,723) |
| 2021 | $3,483 | 8 | Becton, Dickinson and Company ($3,483) |
| 2020 | $11,741 | 12 | CSL Behring ($9,497) |
| 2019 | $2,971 | 5 | Becton, Dickinson and Company ($2,971) |
| 2018 | $6,869 | 5 | CSL Behring ($4,095) |
| 2017 | $1,845 | 4 | Becton, Dickinson and Company ($1,845) |
All Payment Transactions
59 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | Becton, Dickinson and Company | Horizon (Device) | Royalty or License | Cash or cash equivalent | $42.93 | General |
| Category: Reagents | ||||||
| 11/20/2024 | Becton, Dickinson and Company | — | Royalty or License | Cash or cash equivalent | $1,056.17 | General |
| 08/22/2024 | Becton, Dickinson and Company | Horizon (Device) | Royalty or License | Cash or cash equivalent | $15.60 | General |
| Category: Reagents | ||||||
| 08/21/2024 | Becton, Dickinson and Company | — | Royalty or License | Cash or cash equivalent | $924.45 | General |
| 05/21/2024 | Becton, Dickinson and Company | — | Royalty or License | Cash or cash equivalent | $1,422.47 | General |
| 05/21/2024 | Becton, Dickinson and Company | Horizon (Device) | Royalty or License | Cash or cash equivalent | $2.37 | General |
| Category: Reagents | ||||||
| 02/20/2024 | Becton, Dickinson and Company | — | Royalty or License | Cash or cash equivalent | $687.74 | General |
| 02/20/2024 | Becton, Dickinson and Company | Horizon (Device) | Royalty or License | Cash or cash equivalent | $18.29 | General |
| Category: Reagents | ||||||
| 11/17/2023 | Becton, Dickinson and Company | — | Royalty or License | Cash or cash equivalent | $837.27 | General |
| 11/17/2023 | Becton, Dickinson and Company | — | Royalty or License | Cash or cash equivalent | $31.35 | General |
| 11/17/2023 | Becton, Dickinson and Company | Horizon (Device) | Royalty or License | Cash or cash equivalent | $6.40 | General |
| Category: Reagents | ||||||
| 08/24/2023 | Becton, Dickinson and Company | — | Royalty or License | Cash or cash equivalent | $1,189.91 | General |
| 08/24/2023 | Becton, Dickinson and Company | Horizon (Device) | Royalty or License | Cash or cash equivalent | $21.57 | General |
| Category: Reagents | ||||||
| 05/22/2023 | Becton, Dickinson and Company | — | Royalty or License | Cash or cash equivalent | $741.39 | General |
| 05/22/2023 | Becton, Dickinson and Company | Horizon (Device) | Royalty or License | Cash or cash equivalent | $18.21 | General |
| Category: Reagents | ||||||
| 02/22/2023 | Becton, Dickinson and Company | — | Royalty or License | Cash or cash equivalent | $862.24 | General |
| 02/22/2023 | Becton, Dickinson and Company | Horizon (Device) | Royalty or License | Cash or cash equivalent | $24.89 | General |
| Category: Reagents | ||||||
| 11/21/2022 | Becton, Dickinson and Company | FACSVia (Device) | Royalty or License | Cash or cash equivalent | $821.87 | General |
| Category: Cell Analysis | ||||||
| 11/21/2022 | Becton, Dickinson and Company | FACSVia (Device) | Royalty or License | Cash or cash equivalent | $5.44 | General |
| Category: Cell Analysis | ||||||
| 08/25/2022 | Becton, Dickinson and Company | FACSVia (Device) | Royalty or License | Cash or cash equivalent | $939.70 | General |
| Category: Cell Analysis | ||||||
| 08/25/2022 | Becton, Dickinson and Company | FACSVia (Device) | Royalty or License | Cash or cash equivalent | $24.36 | General |
| Category: Cell Analysis | ||||||
| 05/25/2022 | Becton, Dickinson and Company | FACSVia (Device) | Royalty or License | Cash or cash equivalent | $12.69 | General |
| Category: Cell Analysis | ||||||
| 05/24/2022 | Becton, Dickinson and Company | FACSVia (Device) | Royalty or License | Cash or cash equivalent | $927.12 | General |
| Category: Cell Analysis | ||||||
| 05/24/2022 | Becton, Dickinson and Company | FACSVia (Device) | Royalty or License | Cash or cash equivalent | $25.92 | General |
| Category: Cell Analysis | ||||||
| 02/23/2022 | Becton, Dickinson and Company | FACSVia (Device) | Royalty or License | Cash or cash equivalent | $965.65 | General |
| Category: Cell Analysis | ||||||
About Dr. David Sachs, M.D
Dr. David Sachs, M.D is a Clinical & Laboratory Immunology healthcare provider based in Boston, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1013089903.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Sachs, M.D has received a total of $38,533 in payments from pharmaceutical and medical device companies, with $4,170 received in 2024. These payments were reported across 59 transactions from 2 companies. The most common payment nature is "Royalty or License" ($24,941).
Practice Information
- Specialty Clinical & Laboratory Immunology
- Location Boston, MA
- Active Since 11/15/2006
- Last Updated 07/08/2007
- Taxonomy Code 207KI0005X
- Entity Type Individual
- NPI Number 1013089903
Products in Payments
- BD Pharmingen (Device) $9,597
- FACSVia (Device) $3,723
- BD PHARMINGEN (Device) $2,971
- BD OptiBuild (Device) $747.68
- Horizon (Device) $150.26
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Clinical & Laboratory Immunology Doctors in Boston
Dr. John Leung, M.d, M.D
Clinical & Laboratory Immunology — Payments: $427,218
Dr. Lynda Schneider, Md, MD
Clinical & Laboratory Immunology — Payments: $34,278
Dr. Paul Maglione, Md, Phd, MD, PHD
Clinical & Laboratory Immunology — Payments: $32,756
Dr. Anne Goldfeld, M.d, M.D
Clinical & Laboratory Immunology
Lisa Hirschhorn, M.d, M.D
Clinical & Laboratory Immunology
Fayhan Alroqi, M.d, M.D
Clinical & Laboratory Immunology